Venaxis files for CE Mark approval for European commercialization

Venaxis files for CE Mark approval for European commercialization

CASTLE ROCK - Venaxis Inc. (Nasdaq: APPY) has filed for CE Mark approval in Europe for APPY 1, its blood-based appendicitis test, the company announced. Venaxis said it expects to obtain CE... Read More

By: Steve Wednesday December 26, 2012 0 comments Tags: appendicitis, APPY 1, Castle Rock, CE Mark, Don Hurd, Venaxis